Intervention

Carmustine

ClinicalTrials.gov intervention label

Clinical trials5
Recruiting0
Common conditions25
Lead sponsors shown4
Advertisement

Clinical trials

5 shown
Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer PatientsNCT02670109 · 2018-02-01
UNKNOWN
HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV InfectionNCT02343666 · 2016-08-15
WITHDRAWN
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell TransplantNCT02797470 · 2016-06-23
ACTIVE_NOT_RECRUITING
Autologous Stem Cell Transplant for Neurologic Autoimmune DiseasesNCT00716066 · 2008-06-01
ACTIVE_NOT_RECRUITING
Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast CancerNCT00002836 · 1995-09-26
COMPLETED

Common conditions

Autoimmune Disease1Autoimmune Nervous System Disorder1Autologous Transplant Autoimmune1Breast Cancer1Central Nervous System Vasculitis1Cerebellar Degeneration1Chronic Inflammatory Demyelinating Polyneuropathy1CIDP Transplant1HCT for Neurologic Autoimmune Disorders1HIV Infection1Human Immunodeficiency Virus 1 Positive1Lambert Eaton Myasthenic Syndrome1Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma1MS Stem Cell Transplant1Multiple Sclerosis Stem Cell Transplant1Multiple Sclerosis Transplant1Myasthenia Gravis1Myasthenia Gravis Transplant1Neurologic Autoimmune Disease1Neuromyelitis Optica1Opsoclonus Myoclonus Syndrome1Plasmablastic Lymphoma1Rasmussen Subacute Encephalitis1Recurrent Adult Hodgkin Lymphoma1Recurrent Adult Non-Hodgkin Lymphoma1

Trial status mix

ACTIVE_NOT_RECRUITING2
COMPLETED1
UNKNOWN1
WITHDRAWN1

Phase mix

PHASE23
PHASE12
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.